Elevated interleukin-6 is associated with severity of COVID-19: A meta-analysis

J Med Virol. 2021 Jan;93(1):35-37. doi: 10.1002/jmv.26085. Epub 2020 Oct 30.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • COVID-19 / immunology*
  • COVID-19 / mortality
  • Critical Illness
  • Humans
  • Inflammation / virology
  • Interleukin-6 / blood*
  • Severity of Illness Index

Substances

  • Biomarkers
  • IL6 protein, human
  • Interleukin-6